Skip to content
value.today

Craneware plc vs GoodRx

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • GoodRx is the larger company by market value: $1.2 B against $1.0 B for Craneware plc, 1.1 times as much (market caps of Aug 1, 2026 for Craneware plc and Oct 14, 2026 for GoodRx). Craneware plc's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • GoodRx had more revenue: $797 M in the year to December 2025 against $165 M for Craneware plc in the year to June 2022.
  • GoodRx earned more: net income of $30 M against $9 M for Craneware plc.
  • Craneware plc keeps more of each dollar of sales: a net margin of 5.5% against 3.8% for GoodRx.
  • On price to earnings, Craneware plc trades at 113.8× and GoodRx at 72.4×: investors pay more for each dollar of Craneware plc's profit.

Market value, the same start = 100

From Jan 2021: how each one's value moved, whatever its size.

03468102136202120222023202420252026Craneware plc 121GoodRx 7

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$1B$1B2019202020212022202320242025GoodRx $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureCraneware plc
CRW.L · #9,217 in the world
GoodRx
GDRX · #8,585 in the world
Profile
Country🇬🇧 UK🇺🇸 USA
SectorHealthcareHealthcare
IndustryHealthcare Information ServicesHealthcare Information Services
Founded—2011
Size
Market cap$1.0 B$1.2 B
Revenue$165 M$797 M
Net income$9 M$30 M▲ best
Employees—954
Valuation
P/E ratio114×72.4×
Price to sales6.2×1.5×
Price to book3.1×1.9×
Free cash flow yield—14.0%
Profitability
Operating margin—11.0%
Net margin—3.8%
Return on equity—4.5%
Return on invested capital—5.8%
Growth
Revenue growth—0.6%
Revenue growth, 3 years a year—1.3%
Earnings per share growth—125.0%
Financial strength
Debt to equity—0.8×
Net debt to EBITDA—1.4×
Cash
Free cash flow margin—20.6%
Shareholder returns
Shareholder yield—18.4%
Altman Z-score zone—distress
Data as ofMarket cap Aug 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Craneware plc or GoodRx?

GoodRx is the larger company by market value: $1.2 B against $1.0 B for Craneware plc, 1.1 times as much (market caps of Aug 1, 2026 for Craneware plc and Oct 14, 2026 for GoodRx). Craneware plc's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, Craneware plc or GoodRx?

GoodRx had more revenue: $797 M in the year to December 2025 against $165 M for Craneware plc in the year to June 2022. GoodRx earned more: net income of $30 M against $9 M for Craneware plc.

Which is more profitable, Craneware plc or GoodRx?

Craneware plc keeps more of each dollar of sales: a net margin of 5.5% against 3.8% for GoodRx.

Is Craneware plc cheaper than GoodRx?

On price to earnings, Craneware plc trades at 113.8× and GoodRx at 72.4×: investors pay more for each dollar of Craneware plc's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.